Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside/Ferric Derisomaltose and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (Phosphare-IDA-04)

Next Previous
X
Search
Trial Profile

A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside/Ferric Derisomaltose and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (Phosphare-IDA-04)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric derisomaltose (Primary) ; Ferric carboxymaltose
  • Indications Iron deficiency anaemia
  • Focus Adverse reactions
  • Acronyms IDA-04; The PHOSPHARE-IDA04
  • Sponsors Pharmacosmos

    • Most Recent Events

    • 25 Nov 2021 Results (n=242) of pooled secondary analysis of two identically designed, clinical trials PHOSPHARE IDA-04 and PHOSPHARE IDA-05 in the Journal of Clinical Endocrinology and Metabolism
    • 04 Feb 2020 Results of pooled analysis assessing risk of hypophosphatemia by using data from two studies including this study published in the JAMA: the Journal of the American Medical Association.
    • 25 Mar 2019 Primary endpoint (Incidence of hypophosphatemia (defined as s-phosphate 2 mg/dL)) has been met, according to the Pharmacosmos media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top